Our portfolio
Macure Pharma benefits from a strong portfolio of hospital therapeutics. Our range of therapeutics includes among others allergy, cardiology, oncology etc. We market and sell our range of niche hospital therapeutics across Europe and constantly aim to improve our portfolio. Below selection only represents a few examples from our present portfolio.
Amikacin Macure 250 mg/ml solution for injection
Active Substance: Amikacinsulfat
Cloxacillin Macure 1g powder for solution for injection or infusion
Active Substance: Cloxacillin
Deponit® transdermal patches
Active Substance: Glyceryl trinitrate
HTK Solution
Active Substance: HTK solution
Isoprenaline Macure 0,2mg/ml concentrate for solution for infusion
Active Substance: Isoprenaline
Lorazepam Macure 4 mg/ml solution for injection
Active Substance: Lorazepam
Metopocor ® 1 mg/ml solution for injection
Active Substance: Metopolol
Methylene Blue 1%
Active Substance: Methylene Blue
Milnocor® 1 mg/ml, solution for injection or infusion
Active Substance: Milrinone
Noradrenalin Macure 1 mg/ml concentrate for solution
Active Substance: Noradrenaline tratrate
Palonosetron Macure 250 micrograms solution for injection
Active Substance: Palonosetron
Perlinganit® 1mg/ml solution for infusion
Active Substance: Glyceryl trinitrate
Zyrlex®
Active Substance: Cetrizine HCl
For further information, product resumes can be found here:
Denmark – http://produktresume.dk/AppBuilder/search
Finland – https://www.fimea.fi/en/web/en/databases_and_registeries/fimeaweb
Norway – https://legemiddelverket.no/
Sweden – https://lakemedelsverket.se/
United Kingdom – https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency